Rezolute offers 22M shares at $3.87 plus warrants
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rezolute, Inc. (RZLT) is offering 22,040,976 shares of common stock and pre-funded warrants to purchase up to 3,800,000 shares of common stock. The offering price is $3.87 per share and $3.869 per warrant. Estimated net proceeds are approximately $93.5 million. Rezolute expects to use the proceeds with existing cash for ersodetug commercialization preparation, working capital and general corporate purposes; it estimates the combined funds will cover operating expenses and capital expenditures for 24 months. Purchasers face immediate net tangible book value dilution of $2.36 per share.
In tumor HI, preliminary upLIFT results indicate the primary efficacy endpoint was achieved: 13 of 16 participants met the responder criterion, including 12 who completely discontinued IV glucose. Three participants remain in the pivotal period, two not yet responders. Final results are expected by mid-December 2026, with FDA discussions expected in the first quarter of 2027; Rezolute cautions that the preliminary results may change.
For congenital HI, the sunRIZE study did not meet its primary or key secondary endpoint. After reviewing submitted data, the FDA encouraged a Type B pre-BLA meeting but did not opine on approvability.
How this balance works
Rhea-AI gives every point it takes from this document a weight. Minor counts 1, Moderate 3 and Major 9, so one Major point outweighs several Minor ones. The bar adds up the weights on each side, and when neither side holds more than 65% of the total the balance reads Mixed.
It reads the document as published, with the same rules for every company, and it does not look at what the market expected or at how the stock traded, so a point can be objectively good on a day the stock falls.
Rhea-AI Sentiment measures something else, the tone of the wording.
Hollow bars mark forward-looking points. How the balance works
Positive
- Major pointPreliminary upLIFT results report 13 responders among 16 enrollees.
- Moderate point. Forward-looking: it has not happened yet and may not happen.Rezolute estimates existing cash plus proceeds will cover operating expenses and capital expenditures for 24 months.
Negative
- Major point. Forward-looking: it has not happened yet and may not happen.The offering entails $2.36 per-share immediate dilution in net tangible book value.
- Major pointThe congenital HI sunRIZE study missed both primary and key secondary endpoints.
Filing Explained
The underwriters expect delivery on or about
Key Figures
Key Terms
net tangible book value financial
cashless exercise technical
responder criterion medical
glucose infusion rate medical
pre-Biologics License Application regulatory
Offering Details
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
How many shares and pre-funded warrants is RZLT offering?
How much net proceeds does RZLT expect from the offering?
What are the preliminary upLIFT results for RZLT in tumor HI?
Can RZLT pre-funded warrants be traded or exercised without cash?
AI-generated analysis. How Rhea-AI works. Not financial advice.
Pre-Funded Warrants to Purchase up to 3,800,000 Shares of
Common Stock
| | | |
Per Share
|
| |
Per Pre-Funded
Warrant |
| |
Total
|
| |||||||||
|
Offering Price
|
| | | $ | 3.8700 | | | | | | 3.8690 | | | | | | 100,000,777.1200 | | |
|
Underwriting discounts and commissions paid by us(1)
|
| | | $ | 0.2322 | | | | | | 0.2322 | | | | | | 6,000,274.6272 | | |
|
Proceeds to us, before expenses(2)
|
| | | $ | 3.6378 | | | | | | 3.6368 | | | | | | 94,000,502.4928 | | |
| |
Morgan Stanley
|
| |
Guggenheim Securities
|
| |
Cantor
|
|
| |
H.C. Wainwright & Co.
|
| |
Jones
|
|
| |
Maxim Group LLC
|
| |
Lake Street
|
|
| |
ABOUT THIS PROSPECTUS SUPPLEMENT
|
| | | | S-1 | | |
| |
FORWARD-LOOKING STATEMENTS
|
| | | | S-2 | | |
| |
PROSPECTUS SUPPLEMENT SUMMARY
|
| | | | S-3 | | |
| |
THE OFFERING
|
| | | | S-8 | | |
| |
RISK FACTORS
|
| | | | S-10 | | |
| |
USE OF PROCEEDS
|
| | | | S-14 | | |
| |
DILUTION
|
| | | | S-15 | | |
| |
DESCRIPTION OF SECURITIES
|
| | | | S-16 | | |
| |
CERTAIN MATERIAL U.S. FEDERAL INCOME TAX CONSIDERATIONS FOR NON-U.S. HOLDERS
|
| | | | S-18 | | |
| |
UNDERWRITING
|
| | | | S-24 | | |
| |
LEGAL MATTERS
|
| | | | S-33 | | |
| |
EXPERTS
|
| | | | S-33 | | |
| |
WHERE YOU CAN FIND ADDITIONAL
INFORMATION |
| | | | S-34 | | |
| |
INCORPORATION BY REFERENCE
|
| | | | S-34 | | |
| |
ABOUT THIS PROSPECTUS
|
| | | | 1 | | |
| |
SPECIAL NOTE REGARDING FORWARD-LOOKING STATEMENTS
|
| | | | 2 | | |
| |
THE COMPANY
|
| | | | 3 | | |
| |
RISK FACTORS
|
| | | | 8 | | |
| |
USE OF PROCEEDS
|
| | | | 9 | | |
| |
DESCRIPTION OF DEBT SECURITIES
|
| | | | 10 | | |
| |
DESCRIPTION OF CAPITAL STOCK
|
| | | | 17 | | |
| |
DESCRIPTION OF WARRANTS
|
| | | | 19 | | |
| |
DESCRIPTION OF PURCHASE CONTRACTS
|
| | | | 22 | | |
| |
DESCRIPTION OF DEPOSITARY
SHARES |
| | | | 23 | | |
| |
PLAN OF DISTRIBUTION
|
| | | | 27 | | |
| |
WHERE YOU CAN FIND MORE INFORMATION
|
| | | | 30 | | |
| |
INCORPORATION BY REFERENCE
|
| | | | 30 | | |
| |
LEGAL MATTERS
|
| | | | 32 | | |
| |
EXPERTS
|
| | | | 32 | | |
| |
Offering Price per share
|
| | | | | | | | | $ | 3.87 | | |
| |
Historical net tangible book value per share as of September 30, 2026
|
| | | $ | 0.89 | | | | | | | | |
| |
Increase in net tangible book value per share attributable to this offering
|
| | | $ | 0.62 | | | | | | | | |
| |
As adjusted net tangible book value per share after this offering
|
| | | | | | | | | $ | 1.51 | | |
| |
Dilution per share to investors participating in this offering
|
| | | | | | | | | $ | 2.36 | | |
|
Underwriter
|
| |
Number of Shares
To Be Purchased |
| |
Number of Pre-
Funded Warrants To Be Purchased |
| ||||||
|
Morgan Stanley & Co. LLC
|
| | | | 11,681,719 | | | | | | 2,014,000 | | |
|
Guggenheim Securities, LLC
|
| | | | 3,912,273 | | | | | | 674,500 | | |
|
Cantor Fitzgerald & Co.
|
| | | | 3,802,068 | | | | | | 655,500 | | |
|
H.C. Wainwright & Co., LLC
|
| | | | 881,639 | | | | | | 152,000 | | |
|
JonesTrading Institutional Services LLC
|
| | | | 881,639 | | | | | | 152,000 | | |
|
LakeStreet Capital Markets, LLC
|
| | | | 440,819 | | | | | | 76,000 | | |
|
Maxim Group LLC
|
| | | | 440,819 | | | | | | 76,000 | | |
|
Total:
|
| | | | 22,040,976 | | | | | | 3,800,000 | | |
| | | |
Per Share
|
| |
Number of
Pre-Funded Warrants |
| |
Total
|
| |||||||||
|
Offering price
|
| | | $ | 3.8700 | | | | | | 3.8690 | | | | | | 100,000,777.12 | | |
|
Underwriting discounts and commissions to be paid by us
|
| | | | 0.2322 | | | | | | 0.2322 | | | | | | 6,000,274.63 | | |
|
Proceeds, before expenses, to us
|
| | | $ | 3.6378 | | | | | | 3.6368 | | | | | | 94,000,502.49 | | |
275 Shoreline Drive, Suite 500
Redwood City, CA 94065
(650) 206-4507
Debt Securities
Common Stock
Preferred Stock
Warrants
Subscription Rights
Purchase Contracts
Depositary Shares
Units
| | | |
Page
|
| |||
|
ABOUT THIS PROSPECTUS
|
| | | | 1 | | |
|
SPECIAL NOTE REGARDING FORWARD-LOOKING STATEMENTS
|
| | | | 2 | | |
|
THE COMPANY
|
| | | | 3 | | |
|
RISK FACTORS
|
| | | | 8 | | |
|
USE OF PROCEEDS
|
| | | | 9 | | |
|
DESCRIPTION OF DEBT SECURITIES
|
| | | | 10 | | |
|
DESCRIPTION OF CAPITAL STOCK
|
| | | | 17 | | |
|
DESCRIPTION OF WARRANTS
|
| | | | 19 | | |
|
DESCRIPTION OF PURCHASE CONTRACTS
|
| | | | 22 | | |
|
DESCRIPTION OF DEPOSITARY SHARES
|
| | | | 23 | | |
|
PLAN OF DISTRIBUTION
|
| | | | 27 | | |
|
WHERE YOU CAN FIND MORE INFORMATION
|
| | | | 30 | | |
|
INCORPORATION BY REFERENCE
|
| | | | 30 | | |
|
LEGAL MATTERS
|
| | | | 32 | | |
|
EXPERTS
|
| | | | 32 | | |
275 Shoreline Drive, Suite 500
Redwood City, CA 94065
(650) 206-4507
Pre-Funded Warrants to Purchase up to 3,800,000
Shares of Common Stock
| |
Morgan Stanley
|
| |
Guggenheim Securities
|
| |
Cantor
|
|
| |
H.C. Wainwright & Co.
|
| |
Jones
|
|
| |
Maxim Group LLC
|
| |
Lake Street
|
|